Palabras clave
Terapia de Reposición hormonal
Tratamiento
Riesgos y Beneficios
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Exponer los principales efectos de la terapia hormonal sustitutiva en diferentes sistemas del organismo femenino posmenopáusico. Métodos: Revisión integradora de la literatura mediante investigación bibliográfica de abordaje cualitativo y carácter descriptivo utilizando las bases de datos National Library of Medicine (PubMed) y Bivlioteca Virtual en Salud (BVS). "Hormone Replacement Therapy" y "Menopause" fueron los descriptores utilizados, en lengua inglesa, que se encuentran en los Descritores de Ciencias de la Salud.Resultados: Todos los artículos revisados evaluaron los beneficios y perjuicios de la prescripción de la terapia hormonal sustitutiva en mujeres posmenopáusicas, produciendo un estudio de las posibles mejoras o resultados negativos de la medicación en diversos escenarios clínicos. Consideraciones Finales: El estudio propuesto consideró que la terapia de reemplazo hormonal presenta riesgos y beneficios que deben ser evaluados antes de prescribir cualquier tipo de hormona. Las mujeres que ya tienen síntomas severos y moderados, principalmente xerostomía, síntomas vulvovaginales y vasomotores, pueden necesitar usar la terapia para mejorar su calidad de vida, debido a la eficacia comprobada. Para ello, se debe individualizar y realizar consultas periódicas para evaluar la mejoría de las quejas y nuevas conductas, si es posible suspender la medicación.
Referencias
KLING JM, et al. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2019; 317(6): 912–920.
ZHANG L, et al. Menopausal Symptoms and Associated Social and Environmental Factors in Midlife Chinese Women. Clinical Interventions in Aging, 2020; (15): 2195-2208.
VELENTZIS LS, et al. Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study. PLoS One, 2021; 16(8): e0253725.
SIMON JA, et al. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms. Menopause, 2019; 26(5): 506–512.
CHLEBOWSKI RT, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women‘s Health Initiative Randomized Clinical Trials. JAMA, 2020; 324(4): 369-380.
MIRKIN S, et al. Relationship vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone. Menopause, 2019; 26(6): 637–642.
DIEM SJ, et al. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause, 2018; 25(10): 1086–1093.
GORDON JL, et al. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease. The Journal of Clinical Endocrinology & Metabolis, 2020; 105(5): 2050–2060.
HERRERA AY, et al. Estradiol Therapy After Menopause Mitigates Effects of Stress on Cortisol and Working Memory. The Journal of Clinical Endocrinology & Metabolism, 2017; 102(12): 4457–4466.
El KHOUDARY SR, et al. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial. Menopause, 2020; 27(3): 255–262.
JAYACHANDRAN M, et al. Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study. Menopause, 2020; 27(3): 305–310.
Al-ROUSAN T, et al. Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women's Health Initiative. PLoS One, 2018; 13(12): e0207509.
El KHOUDARY SR, et al. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial. JAHA, 2019; 8(15): e012763
OBER BA, et al. Effects of Hormone Therapy on List and Story Recall in Post-Menopausal Women. Experimental Aging Research, 2019; 45(3): 199–222.
PRENTICE RL, et al. Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50–59 Years of Age. American Journal of Epidemiology, 2021; 190(3): 365–375.
MANSON JE, et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA, 2017; 318(10): 927.
SUH MJ, et al. Effects of endogenous and exogenous o estrogen exposure on hearing level in postmenopausal women: A cross‐sectional study. Clinical Otolaryngology, 2021; 46(3): 508–514.
JU R, et al. Sexual dysfunction in Chinese women at different reproductive stages and the positive effect of hormone replacement therapy in the early postmenopause. The European Journal of Contraception & Reproductive Health Care, 2021; 26(3): 246–54.
HANSEN ESH, et al. Hormone Replacement Therapy and Development of New Asthma. Chest, 2021; 160(1): 45–52.
KHIALANI D, et al. Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor. J Thromb Haemost., 2021; 19(7): 1729–1737.
NWARU BI, et al. Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice, 2021; 9(7): 2751-2760.
PARK CW, et al. Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial. Climacteric, 2021; 24(4): 408–414.
AHN SY, et al. The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey. Scientific Reports, 2021; 11(1):15418.
WANG L, et al. Role of hormone replacement therapy in relieving oral dryness symptoms in postmenopausal women: a case control study. BMC Oral Health, 2021; 615.